INDIGO Home University of Illinois at Urbana-Champaign logo uic building uic pavilion uic student center

An Integrated Bioinformatics Approach Identifies Elevated Cyclin E2 Expression and E2F Activity as Distinct Features of Tamoxifen Resistant Breast Tumors

Show full item record

Bookmark or cite this item: http://hdl.handle.net/10027/8398

Files in this item

File Description Format
PDF journal.pone.0022274.pdf (523KB) (no description provided) PDF
Title: An Integrated Bioinformatics Approach Identifies Elevated Cyclin E2 Expression and E2F Activity as Distinct Features of Tamoxifen Resistant Breast Tumors
Author(s): Huang, Lei; Zhao, Shuangping; Frasor, Jonna M.; Dai, Yang
Subject(s): breast tumors genes
Abstract: Approximately half of estrogen receptor (ER) positive breast tumors will fail to respond to endocrine therapy. Here we used an integrative bioinformatics approach to analyze three gene expression profiling data sets from breast tumors in an attempt to uncover underlying mechanisms contributing to the development of resistance and potential therapeutic strategies to counteract these mechanisms. Genes that are differentially expressed in tamoxifen resistant vs. sensitive breast tumors were identified from three different publically available microarray datasets. These differentially expressed (DE) genes were analyzed using gene function and gene set enrichment and examined in intrinsic subtypes of breast tumors. The Connectivity Map analysis was utilized to link gene expression profiles of tamoxifen resistant tumors to small molecules and validation studies were carried out in a tamoxifen resistant cell line. Despite little overlap in genes that are differentially expressed in tamoxifen resistant vs. sensitive tumors, a high degree of functional similarity was observed among the three datasets. Tamoxifen resistant tumors displayed enriched expression of genes related to cell cycle and proliferation, as well as elevated activity of E2F transcription factors, and were highly correlated with a Luminal intrinsic subtype. A number of small molecules, including phenothiazines, were found that induced a gene signature in breast cancer cell lines opposite to that found in tamoxifen resistant vs. sensitive tumors and the ability of phenothiazines to down-regulate cyclin E2 and inhibit proliferation of tamoxifen resistant breast cancer cells was validated. Our findings demonstrate that an integrated bioinformatics approach to analyze gene expression profiles from multiple breast tumor datasets can identify important biological pathways and potentially novel therapeutic options for tamoxifen-resistant breast cancers.
Issue Date: 2011-07-15
Publisher: Public Library of Science
Citation Info: Huang, L., Zhao, S., Frasor, J. M., & Dai, Y. 2011. An Integrated Bioinformatics Approach Identifies Elevated Cyclin E2 Expression and E2F Activity as Distinct Features of Tamoxifen Resistant Breast Tumors. PLoS One, 6(7): e22274. DOI: 10.1371/journal.pone.0022274.
Type: Article
Description: © 2011 Huang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. DOI: 10.1371/journal.pone.0022274.
URI: http://hdl.handle.net/10027/8398
ISSN: 1932-6203
Date Available in INDIGO: 2012-06-27
 

This item appears in the following Collection(s)

Show full item record

Statistics

Country Code Views
United States of America 123
China 22
United Kingdom 12
Netherlands 3
Ukraine 2

Browse

My Account

Information

Access Key